【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) to Central Nervous System Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) to Central Nervous System Clinical Trials 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
CSL Limited 30
Clinical Trial Overview of CSL Limited 30
LFB S.A. 31
Clinical Trial Overview of LFB S.A. 31
Biogen Idec Inc. 32
Clinical Trial Overview of Biogen Idec Inc. 32
Takeda Pharmaceutical Company Limited 33
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 33
Octapharma AG 34
Clinical Trial Overview of Octapharma AG 34
Novartis AG 35
Clinical Trial Overview of Novartis AG 35
Kedrion S.p.A. 36
Clinical Trial Overview of Kedrion S.p.A. 36
Grifols, S.A. 37
Clinical Trial Overview of Grifols, S.A. 37
Grifols Deutschland Gmbh 38
Clinical Trial Overview of Grifols Deutschland Gmbh 38
GeNeuro SA 39
Clinical Trial Overview of GeNeuro SA 39
Clinical Trial Overview of Top Institutes / Government 40
National Center for Research Resources 40
Clinical Trial Overview of National Center for Research Resources 40
Aarhus University 41
Clinical Trial Overview of Aarhus University 41
Erasmus MC 42
Clinical Trial Overview of Erasmus MC 42
State University of New York at Buffalo 43
Clinical Trial Overview of State University of New York at Buffalo 43
Stony Brook University 44
Clinical Trial Overview of Stony Brook University 44
University of Cologne 45
Clinical Trial Overview of University of Cologne 45
Northwestern University 46
Clinical Trial Overview of Northwestern University 46
Centre Hospitalier Universitaire de Saint Etienne 47
Clinical Trial Overview of Centre Hospitalier Universitaire de Saint Etienne 47
Oregon Health and Science University 48
Clinical Trial Overview of Oregon Health and Science University 48
Rigshospitalet 49
Clinical Trial Overview of Rigshospitalet 49
Five Key Clinical Profiles 50
Appendix 92
Abbreviations 92
Definitions 92
Research Methodology 93
Secondary Research 93
About GlobalData 94
Contact Us 94
Disclaimer 94
Source 94
【レポート販売概要】
■ タイトル：慢性炎症性脱髄性多発神経炎(CIDP)：グローバル臨床試験レビュー（2014年上半期）■ 英文：Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Global Clinical Trials Review, H1, 2014
■ 発行日：2014年5月30日
■ 調査会社：GlobalData
■ 商品コード：GDHC2198CTIDB
■ 調査対象地域：グローバル
- 細胞分析の世界市場：細胞分析装置、細胞分析消耗品About Cell Analysis Cell analysis helps identify and map many of the basic biochemical and physical processes of life. Bio-specimen preparation, cell and tissue separation, and characterization products are used to isolate and assess cells. Cell analysis products are used by various industries including biotechnology, pharmaceutical, research, and contract research organizations (CROs). They have …
- T3 Uptakeの市場別医療検査数および販売予測This new report from Venture Planning Group provides analysis of T3 Uptake testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories P …
- 鎮静作用(Sedation)の治療薬パイプライン動向（2015年上半期版）Sedation - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Sedation - Pipeline Review, H1 2015’, provides an overview of the Sedation’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Sedation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administr …
- 顕微鏡的多発性血管炎(Microscopic Polyangiitis (MPA)）：治療薬のグローバル治験動向（2014年下半期）Microscopic Polyangiitis (MPA) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Microscopic Polyangiitis (MPA) Global Clinical Trials Review, H2, 2014" provides data on the Microscopic Polyangiitis (MPA) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Microscopic Polyangiitis (MPA). It includes an o …
- 膿痂疹(Impetigo)：世界の治験レビュー（2015年上半期版）Impetigo Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Impetigo Global Clinical Trials Review, H1, 2015" provides an overview of Impetigo clinical trials scenario. This report provides top line data relating to the clinical trials on Impetigo. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe …
- スパイス（香辛料）及びスティミュラント（コーヒー、ココア、茶）の世界市場About Spices and Stimulants Spices and stimulants are plant products. Spices constitute a large variety of phytonutrients and antioxidants. Primarily used for their palatability, flavor, and aroma (derived from phytochemicals), spices find extensive usage in the culinary industry. Stimulants offer increased vigor temporarily and contain chemicals such as caffeine, l-theanine, theophylline, and the …
- 世界のmiRNA市場展望The recent discovery of miRNA and its wide applicability have sparked off a lot of interest among researchers as well as commercial players. Owing to the same, there are numerous clinical trials being organized all over the world in order to assess the potential of miRNA in diverse fields such as Cancer, Asthma, Heart Disorders, Diabetes, Hepatitis etc. The report, “Global miRNA Market Outlook to …
- Trypanosomiasis：グローバル臨床試験レビューH1, 2013Trypanosomiasis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Trypanosomiasis Global Clinical Trials Review, H1, 2013" provides data on the Trypanosomiasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Trypanosomiasis. It includes an overview of the trial numbers and their recruitment status as …
- モバイルアイデンティティ（ID）管理の世界市場2016-2020About Mobile Identity Management Mobile identity management is an approach that can address both usability and trust concerns in mobile business. It has been a fundamental service for the next-generation mobile telecommunications infrastructure. Mobile identity management is used to identify, acquire, access, and pay for services that follow the user from device to device, location to location, an …
- ピレスロイドの世界市場：ビフェントリン、ペルメトリン、テトラメトリン、シフルトリン、シペルメトリン、デルタメトリンAbout Pyrethroids Pyrethrins are one of the oldest known insecticides and are derived from dried and crushed flower heads of two species of asters: Chrysanthemum cinerariifolium and C. coccineum. High variance in the availability of pyrethrins limited their usage and encouraged the development of synthetic alternatives. Pyrethroids are synthetic insecticides with chemical structures that resemble …
- 世界の精製産業：精製能力および投資動向Global Capacity and Capital Expenditure Outlook for Refineries - New-Build Refinery Pipeline Risks Over-Capacity and Puts Pressure on Refiners Summary The global refining industry, which witnessed a marginal growth rate of 6% since 2010, is expected to rebound and witness a high growth rate of 16% during 2014 to 2019. Asia will dominate the global refining industry, both in terms of capacity growt …
- クラウド型マイクログリッドサービス（MaaS）の世界市場予測2022The microgrid as a service (MaaS) market was valued at USD 774.9 Million in 2015 and is expected to reach USD 2,241.6 Million by 2022, at a CAGR of 15.86% during the forecast period. Reduction in operational costs and negligible upfront investments by MaaS end users, rising demand from MaaS from hospitals, universities, and remote regions, and high investments by governments in microgrid infrastru …
- ドッキングステーションの世界市場2016-2020About Docking Station A docking station is a hardware frame that enables devices such as laptops and hard disk drives to effectively serve as a desktop computer. The interface allow the devices to communicate with large storage drives, printers, and other devices such as music systems The integration of docking stations enhances the user's experience when they need to connect devices such as lapto …
- 保冷材の世界市場：ファイバーグラス、ポリウレタンフォーム、ポリイソシアヌレートフォーム、ポリスチレンフォームAbout cold insulation Insulation is a term used to define inhibition or retardation of dissipation or absorption of heat or electricity. Cold insulation is a technology that has the capability to reduce or eliminate loss of energy from materials, equipment, and infrastructure to obtain energy efficiency. Technavio's analysts forecast the global cold insulation materials market to grow at a CAGR of …
- 海上地震探査装置及びデータ取得の世界市場Overall, spending on marine seismic equipment and acquisition will fall significantly in 2015 after the oil price collapse and then gradually recover in line with oil prices. However it will take years to reach CAPEX levels witnessed in 2014. Visiongain has calculated that in 2015 the global marine seismic equipment market is worth $784.3m and the global acquisition market is worth $4,601.6m. What …
